A drug with the SMILES Cc1sc2ncnc(N3CCC(C(=O)Nc4sc5c(c4C(N)=O)CCC(C)C5)CC3)c2c1C has a human ether-à-go-go related gene (hERG) inhibition at 1uM of 5.001\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
Cc1sc2ncnc(N3CCC(C(=O)Nc4sc5c(c4C(N)=O)CCC(C)C5)CC3)c2c1C
Cc1sc2ncnc(N3CCC(C(=O)Nc4sc5c(c4C(N)=O)CCC(C)C5)CC3)c2c1C
N-(3-carbamoyl-6-methyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-1-(5,6-dimethylthieno[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide